Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
|Slideshows|October 10, 2022
Americans Have not Been Truthful about Following COVID-19 Precautions
Author(s)Grace Halsey
More than 4 in 10 US adults have either misrepresented their COVID-19 status or failed to adhere to public health measures. A new survey found out why.
Advertisement
Close to half of US adults were found to disregard some aspect of COVID-19 public health measures in a new nationwide study led in part by scientists at the Univerity of Utah (U of U) Health and published in JAMA Network Open.
Of the survey's 721 respondents, 42% reported they had misrepresented their COVID-19 health status or failed to follow pandemic precautions .
“Some individuals may think if they fib about their COVID-19 status once or twice, it’s not a big deal,” says Angela Fagerlin, PhD, senior study author and chair of the Department of Population Health Sciences at U of U Health, in a statement. “But if, as our study suggests, nearly half of us are doing it, that’s a significant problem that contributes to prolonging the pandemic.”
The short slide show that follows offers a top-line look at the findings of the study, which was much larger and queried a broader range of behaviors than earlier studies on the topic.
Advertisement
Related to this article
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Advertisement
Advertisement